Asianet Newsable on MSN
Nephro Health IPO day 2: Subscription still low at 13%; GMP, expert calls and key details explained
The Nephro Health IPO experienced a slow response, achieving only 13% subscription by its second day. Despite the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback